Teladoc Health Inc (NYSE:TDOC) Holdings Cut by Riverbridge Partners LLC

Riverbridge Partners LLC lowered its stake in shares of Teladoc Health Inc (NYSE:TDOC) by 0.2% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,750,785 shares of the health services provider’s stock after selling 3,713 shares during the quarter. Teladoc Health accounts for 2.2% of Riverbridge Partners LLC’s investment portfolio, making the stock its 9th biggest position. Riverbridge Partners LLC owned 2.43% of Teladoc Health worth $118,563,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. Westside Investment Management Inc. purchased a new stake in shares of Teladoc Health during the 2nd quarter valued at $26,000. CENTRAL TRUST Co raised its position in shares of Teladoc Health by 82.6% during the 2nd quarter. CENTRAL TRUST Co now owns 378 shares of the health services provider’s stock valued at $27,000 after buying an additional 171 shares in the last quarter. Meridian Wealth Management LLC purchased a new stake in shares of Teladoc Health during the 2nd quarter valued at $27,000. Cornerstone Advisors Inc. raised its position in shares of Teladoc Health by 187.0% during the 2nd quarter. Cornerstone Advisors Inc. now owns 465 shares of the health services provider’s stock valued at $31,000 after buying an additional 303 shares in the last quarter. Finally, Reilly Financial Advisors LLC purchased a new stake in shares of Teladoc Health during the 2nd quarter valued at $33,000.

Several analysts have recently weighed in on the stock. ValuEngine cut shares of Teladoc Health from a “strong-buy” rating to a “buy” rating in a research report on Thursday. Jefferies Financial Group restated a “buy” rating and set a $95.00 price objective on shares of Teladoc Health in a research report on Tuesday, July 2nd. JPMorgan Chase & Co. raised their price objective on shares of Teladoc Health from $82.00 to $83.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. Piper Jaffray Companies set a $87.00 price objective on shares of Teladoc Health and gave the company a “buy” rating in a research report on Friday, August 16th. Finally, Deutsche Bank assumed coverage on shares of Teladoc Health in a research report on Thursday, September 12th. They set a “buy” rating and a $76.00 price objective on the stock. Two analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Teladoc Health currently has a consensus rating of “Buy” and a consensus price target of $79.14.

In other Teladoc Health news, President Peter A. Mcclennen sold 29,412 shares of the firm’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $69.98, for a total value of $2,058,251.76. Following the sale, the president now owns 29,412 shares of the company’s stock, valued at approximately $2,058,251.76. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, President Peter A. Mcclennen sold 13,753 shares of the firm’s stock in a transaction on Monday, July 15th. The stock was sold at an average price of $70.99, for a total transaction of $976,325.47. Following the completion of the sale, the president now directly owns 29,412 shares in the company, valued at approximately $2,087,957.88. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 67,036 shares of company stock worth $4,622,050. 3.95% of the stock is owned by insiders.

TDOC stock opened at $67.45 on Friday. The company has a quick ratio of 7.56, a current ratio of 7.56 and a debt-to-equity ratio of 0.43. Teladoc Health Inc has a 52 week low of $42.08 and a 52 week high of $75.93. The firm’s fifty day moving average is $64.47 and its 200 day moving average is $62.07.

Teladoc Health (NYSE:TDOC) last released its earnings results on Wednesday, July 31st. The health services provider reported ($0.41) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.40) by ($0.01). Teladoc Health had a negative net margin of 21.85% and a negative return on equity of 10.64%. The business had revenue of $130.30 million for the quarter, compared to the consensus estimate of $129.54 million. During the same period in the prior year, the business posted ($0.40) EPS. Teladoc Health’s revenue for the quarter was up 37.8% on a year-over-year basis. On average, research analysts forecast that Teladoc Health Inc will post -1.56 earnings per share for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Read More: Hedge Funds – How They Work For Investors

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit